Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
van de Donk, Niels
Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Future Directions and Challenges
Location: Hall FG
Niels van de Donk
Van Oekelen, Oliver
Icahn School of Medicine at Mount Sinai
(OA-15) S100A8/A9 Promotes T Cell Exhaustion and Impairs Response to Bispecific Therapy in Multiple Myeloma
Location: Room 718
Oliver Van Oekelen
Visram, Alissa
Juravinski Cancer Centre / Hamilton Health Sciences
(OA-20) Temporal Trends in Infectious Risk Among Multiple Myeloma Patients Treated with Daratumumab: A Meta-Analysis
Location: Room 701
Alissa Visram
Tailoring Treatment Across the Spectrum in NDMM
Location: Hall FG
Alissa Visram
Voorhees, Peter
Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
The road ahead: Driving outcomes in RRMM
Location: Hall FG
Peter Voorhees